Drug
Oxaliplatin
Oxaliplatin: highest development phase Approved, developed by Sandoz, Sanofi. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Sandoz, Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| OXALIPLATIN | Approved | |
| OXALIPLATIN | Approved | |
| Oxaliplatin NCT00472849 | Phase 1/2 | Richter's Transformation |
Latest
No recent events.
Follow Oxaliplatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.